Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
Next >
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Biotech and Pharmaceuticals
Eli Lilly and Co
Health & Science
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Novo Nordisk A/S
US: News
Eli Lilly and Co
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
Business News
Business
Investment Strategy
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
Sanofi SA
Business News
Biotechnology
From
CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
July 08, 2024
Tickers
LAWS
Tags
Breaking News: Markets
Dow Jones Industrial Average
Cryptocurrency
From
CNBC.com News
CNBC Daily Open: French far-right advance blocked
July 07, 2024
Tags
Stock markets
Interest Rates
Elections
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Investment strategy
ETF Edge
Wall Street
From
CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
July 04, 2024
Tags
Companies
Health care industry
Pharmaceuticals
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
UnitedHealth Group Inc
Oracle Corp
CVS Health Corp
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Altimmune Inc
Science
Biotech and Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens
June 25, 2024
Tags
Investing
Walt Disney Co
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
US: News
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Companies
Health care industry
Business
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
Breaking News: Markets
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Labor economy
Biotech and Pharmaceuticals
Social issues
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Novo Nordisk A/S
Alphabet Inc
Eli Lilly and Co
From
CNBC.com News
European stocks set for muted open after European Central Bank cut
June 07, 2024
Tags
World Economy
Government and politics
Ibex Ltd
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Employee benefits
Employee healthcare benefits
Health care industry
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Business News
From
CNBC.com News
Cramer's Lightning Round: Apple is a buy
May 28, 2024
Tags
Markets
Market Outlook
stocks
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
Amgen Inc
Markets
Exchange/traded funds
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
Mobile
Teladoc Health Inc
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Novo Nordisk A/S
Science
Uber Technologies Inc
From
CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
May 21, 2024
Tags
AstraZeneca PLC
Europe Markets
Health care industry
From
CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
May 20, 2024
Tags
Hims & Hers Health Inc
Business
Health & Science
From
CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags
Pharmaceuticals
Health & Science
Roche Holding AG
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Alphabet Inc
Eli Lilly and Co
Science
From
CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Science
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Health & Science
Health care industry
Healthy Returns
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
US: News
From
CNBC.com News
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.